CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Open-market buy Chief Executive Officer bought 11,000 shares at $3.90 ($42,900)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
- 8-K Event Regulation FD disclosure
- 4 Open-market buy COO & CFO bought 2,250 shares at $4.45 ($10,013)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $4.08 ($12,240)
- 4 Open-market buy Director bought 5,000 shares at $3.98 ($19,900)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $3.84 ($11,520)
- 4 Open-market buy Chief Executive Officer bought 4,112 shares at $3.96 ($16,284)
- 4 Open-market buy Chief Executive Officer bought 4,480 shares at $3.99 ($17,875)
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
Page 15 of 50 · 983 filings